Irinovid
Brand Name: Irinovid
Generic Name: Irinotecan Hydrochloride Trihydrate
Active
Registration Number
DR-XY46926
Dosage Form
Concentrate Solution for I.V. Infusion
Issuance Date
January 30, 2025
Expiry Date
June 29, 2030
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength20mg/Ml (40mg/2mL and 100mg/5mL)
Packaging2mL (net content) in 2mL-capacity amber glass vial sealed with 13mm butyl coated rubber stopper and sealed with aluminum-plastic cap (Box of 1's) 5mL (net content) in 6mL-capacity amber glass vial sealed with 20mm butyl coated rubber stopper and aluminum-plastic cap (Box of 1's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Irinotecan Hydrochloride TrihydrateActive
Monograph: Irinotecan